Skip to content

13F-HR filed by MFN Partners Management, LP

MFN Partners Management, LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-13, with 11 holding rows worth $717,498,000.

Accession
0001567619-20-015050
Filed
2020-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 11 entries on the cover page, a total value of $717,498,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $717,499,000 with VALUE read as thousands by filing date, 13F file number 028-19231. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHENIERE ENERGY INC COM NEW16411R208Stock2,851,860$137,802,000thousands by filing date
LIBERTY GLOBAL PLCG5480U120SHS CL C6,206,460$133,501,000thousands by filing date
FOLEY TRASIMENE ACQUISTN COR34431F203UNIT 99/99/999910,000,000$106,700,000thousands by filing date
XPO INC COM983793100Stock1,159,426$89,566,000thousands by filing date
CORELOGIC INC21871D103COM1,200,000$80,664,000thousands by filing date
HCA Healthcare Inc40412C101COM565,000$54,839,000thousands by filing date
MYLAN NVN59465109SHS EURO2,750,000$44,220,000thousands by filing date
FIDELITY NATIONAL FINANCIAL31620R303FNF GROUP COM1,400,000$42,924,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM2,427,677$14,348,000thousands by filing date
EVOLUS INC30052C107COM1,420,000$7,526,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock3,338,718$5,409,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-20-015050this filing2020-08-13acceptance time not in the bulk data set